双鹭药业(002038.SZ)参股公司长风药业(02652)预计10月8日在联交所挂牌上市

Group 1 - The core point of the article is that Shuanglu Pharmaceutical (002038.SZ) announced that its associate company, Changfeng Pharmaceutical (02652), is expected to officially list on the Hong Kong Stock Exchange on October 8, 2025 [1] - Changfeng Pharmaceutical plans to offer a total of 41.198 million shares in its global offering, with a price set at HKD 14.75 per share [1]